| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/17/2008 | US20080015201 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015199 Triazolone derivatives |
| 01/17/2008 | US20080015198 Moderate cannabinoid receptors; eating disorders; drug abuse; central nervous system disorders ; anticancer agents; bone disorders; Alzheimer's disease |
| 01/17/2008 | US20080015197 Process for the preparatrion of zopiclone |
| 01/17/2008 | US20080015196 Imidazopyrazines, Imidazopyridines, and Imidazopyrimidines as Crf1 Receptor Ligands |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | US20080015194 Methods and compositions of targeted drug development |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015192 Inhibitors of polo-like kinases |
| 01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
| 01/17/2008 | US20080015190 Inhibitors of Histone Deacetylase |
| 01/17/2008 | US20080015189 Antimicrobial photoinactivation using chalcogen analogs of benzo(A)phenoxazinium dyes |
| 01/17/2008 | US20080015188 Stable pharmaceutical compositions of 2-aza-bicyclo(3.3.0)-octane-3-carboxylic acid derivatives |
| 01/17/2008 | US20080015187 Hiv Integrase Inhibitors |
| 01/17/2008 | US20080015186 Pharmaceutical compositions containing in combination a cannabinoid receptor antagonist and an antipsychotic |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015184 Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015182 Potent PARP Inhibitors |
| 01/17/2008 | US20080015181 Pharmaceutical Compositions Comprising Droxidopa |
| 01/17/2008 | US20080015180 Methods and compositions for treating amyloid-related diseases |
| 01/17/2008 | US20080015179 such as ethyl 3-(1'-methyl-2'-oxospiro[cyclohexane-1,3'-indoline]-4-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate, used for the treatment of nervous system disorders, psychological disorders, autoimmune diseases, gastrointestinal disorders, vision defects, obesity and cardiovascular disorders |
| 01/17/2008 | US20080015178 Benzimidazoles, process for their preparation and use thereof as medicament |
| 01/17/2008 | US20080015177 S1P receptor modulating compounds and use thereof |
| 01/17/2008 | US20080015176 such as dabigatran etexilate in children; congenital heart disease, shunt or catheter thrombosis, pulmonary embolism, stroke in pregnant girls; pediatrics |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015174 Metabolic Disease Treatments |
| 01/17/2008 | US20080015173 Estrogen Receptor Modulators |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015171 Method for increasing absorption of steroid hormones |
| 01/17/2008 | US20080015170 Method of treating menopausal women transdermally with testosterone |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015166 Eicosapentaenoic acid, docosahexaenoic acid, arachidonic acid and at least two distinct oligosaccharides; reduce epithelial paracellular permeability; diarrhea |
| 01/17/2008 | US20080015165 Novel polypeptide |
| 01/17/2008 | US20080015164 Methods and compositions for inactivation of dihydrofolate reductase |
| 01/17/2008 | US20080015161 RNAi modulation of TGF-beta and therapeutic uses thereof |
| 01/17/2008 | US20080015159 Small Synthetic Rna, a Method of Preparing the Same and Uses Thereof |
| 01/17/2008 | US20080015158 By using a double-stranded RNA (dsRNA); neurodegenerative disorder |
| 01/17/2008 | US20080015157 Novel Water-Soluble Prodrugs |
| 01/17/2008 | US20080015156 Novel 2-substituted methyl penam derivatives |
| 01/17/2008 | US20080015155 Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080015143 In Vitro Methods for Detecting Renal Cancer |
| 01/17/2008 | US20080015141 Use of a Novel Polymorphism in the Hsgk1 Gene in the Diagnosis of Hypertonia an Use of the Sgk Gene Family in the Diagnosis and Therapy of the Long Qt Syndrome |
| 01/17/2008 | US20080015140 Disinfecting composition |
| 01/17/2008 | US20080014645 Method for reducing psa levels |
| 01/17/2008 | US20080014623 Nutrient absorption enhancing compositions and methods |
| 01/17/2008 | US20080014614 Labeling of rapamycin using rapamycin-specific methylases |
| 01/17/2008 | US20080014293 Novel compound isolated from ginkgo biloba bark, isolation method thereof and antiplatelet composition containing the same |
| 01/17/2008 | US20080014290 Composition consisting of mannitol powder, calcium carbonate (antacid), benzocaine (topical anesthetic), and starch paste; lozenges; chewing gum; rapid dissolution; drug delivery |
| 01/17/2008 | US20080014288 Zinc-containing treatments for hyperphosphatemia |
| 01/17/2008 | US20080014286 Metal-containing materials |
| 01/17/2008 | US20080014282 Therapeutic, Nutraceutical and Cosmetic Applications for Eggshell Membrane and Processed Eggshell Membrane Preparations |
| 01/17/2008 | US20080014281 Chitin Micro-Particles As An Adjuvant |
| 01/17/2008 | US20080014280 Amorphous pregabalin and process for the preparation thereof |
| 01/17/2008 | US20080014277 Reduced-odor thiol compositions |
| 01/17/2008 | US20080014275 Pharmaceutical suspensions and related methods |
| 01/17/2008 | US20080014274 Enhanced stability phenylephrine liquid compositions |
| 01/17/2008 | US20080014272 Compositions and Methods for Treatment of Chronic Pain Conditions |
| 01/17/2008 | US20080014271 Novel pharmaceutical compositions comprising levetiracetam |
| 01/17/2008 | US20080014269 Oxacarbazepine film-coated tablets |
| 01/17/2008 | US20080014267 Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| 01/17/2008 | US20080014266 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 01/17/2008 | US20080014265 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 01/17/2008 | US20080014264 Novel pharmaceutical compositions comprising levetiracetam |
| 01/17/2008 | US20080014263 Amorphous eprosartan mesylate and process for the preparation thereof |
| 01/17/2008 | US20080014262 Rapidly disintegrating tablet containing polyvinyl alcohol |
| 01/17/2008 | US20080014261 Non-narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| 01/17/2008 | US20080014259 Compositions of R(+) and S(-) Pramipexole and Methods of Using the Same |
| 01/17/2008 | US20080014258 Administering (5-fluorouridine)-5'-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt; actinic keratosis |
| 01/17/2008 | US20080014257 Oral dosage forms |
| 01/17/2008 | US20080014256 having at least one enteric coating; oral bioavailability |
| 01/17/2008 | US20080014255 Liposome bonded with antibody and polyalkylene glycol |
| 01/17/2008 | US20080014254 Stable Crystal Modifications of Dotap Chloride |
| 01/17/2008 | US20080014252 Topical compositions with long lasting effect |
| 01/17/2008 | US20080014250 Bifunctionalized polysaccharides |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014248 Photosensitizer containing indole-3-alkylcarboxylic acid, and kit for photodynamic therapy containing the same |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014244 Implantable medical devices and coatings therefor comprising physically crosslinked block copolymers |
| 01/17/2008 | US20080014239 Multiple heparin molecules that are end-to-side and/or end-to-end connected glycosaminoglycan units attached to a globular core molecule, such as serum albumin, by a spacer such as N-succinylimidyl 3-(2-pyridyldithio)propionate; inhibition of collagen-induced platelet aggregation |
| 01/17/2008 | US20080014238 Implantable medical devices comprising semi-crystalline poly(easter-amide) |
| 01/17/2008 | US20080014232 Two-coat make-up product, its use and a kit containing the make-up product |
| 01/17/2008 | US20080014230 Cosmetic compositions combining a C-glycoside derivative and an N-acylamino amide derivative |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014223 Syrup Composition Comprising Dexibupropen as an Active Ingredient and Method for the Preparation Thereof |
| 01/17/2008 | US20080014207 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 01/17/2008 | US20080014206 drug screening for agents potentially useful in the treatment of Mycobacterium tuberculosis infection; drug resistant antibiotics |
| 01/17/2008 | US20080014201 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
| 01/17/2008 | US20080014200 Combined treatment with 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents |
| 01/17/2008 | US20080014198 Treatment of Cancer With a Combination of an Agent that Perturbs the EGF Signaling Pathway and an Oligonucleotide that Reduces Clusterin Levels |
| 01/17/2008 | US20080014191 Treatment of Protein Misfolding |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080014187 Compositions and Methods for Treating Hypertension and Inflammation |
| 01/17/2008 | US20080014185 Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth |
| 01/17/2008 | US20080014184 Treating fibromyalgia in a subject who has small intestinal bacterial overgrowth (SIBO) by administering a composition comprising a therapeutic agent selected from an antimicrobial agent, an antibiotic, and combinations thereof |
| 01/17/2008 | US20080014175 Methods and Compositions for Viral Enhancement of Cell Killing |
| 01/17/2008 | US20080014173 N-(4,6-dimethyl-2-pyridinyl)-L-valyl- N-(1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)carboxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 01/17/2008 | US20080014170 Drug delivery polyanhydride composition and method |